Sompraz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a combination product containing esomeprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*) infection. Esomeprazole is a proton pump inhibitor (PPI), amoxicillin is a penicillin-class antibiotic, and clarithromycin is a macrolide antibiotic. ## Primary Indications Eradication of *H. pylori* in patients with peptic ulcer disease. ## Adult Dosing The standard adult regimen is one capsule of Sompraz HP taken twice daily for 10 to 14 days. Each capsule contains esomeprazole 20 mg, amoxicillin 500 mg, and clarithromycin 250 mg. This translates to: * **Esomeprazole:** 20 mg twice daily * **Amoxicillin:** 500 mg twice daily * **Clarithromycin:** 250 mg twice daily Maximum duration of therapy is typically 14 days. ## Pediatric Dosing There is no established pediatric dosing for Sompraz HP. Dosing of individual components may be guided by age, weight, and renal/hepatic function if a combination therapy is deemed necessary in pediatric patients. ## Dose Adjustments * **Renal Impairment:** Amoxicillin requires dose adjustment in severe renal impairment (CrCl < 30 mL/min). Clarithromycin dose adjustment is recommended in severe renal impairment (CrCl < 30 mL/min). Esomeprazole generally does not require dose adjustment in renal impairment. Given Sompraz HP is a fixed-dose combination, it may not be suitable for patients requiring dose adjustments for amoxicillin or clarithromycin. * **Hepatic Impairment:** Esomeprazole dose adjustment may be necessary in severe hepatic impairment. Clarithromycin dose adjustment is recommended in moderate to severe hepatic impairment. Amoxicillin typically does not require dose adjustment in hepatic impairment. Given Sompraz HP is a fixed-dose combination, it may not be suitable for patients requiring dose adjustments for esomeprazole or clarithromycin. ## Contraindications * Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, other macrolides, or penicillins. * History of severe hypersensitivity reactions to other beta-lactam antibacterials (e.g., cephalosporins). * Concomitant use with ergotamine or dihydroergotamine. * History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. * Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) that increase the risk of QT prolongation. ## Adverse Effects Common adverse effects include diarrhea, nausea, abdominal pain, headache, taste disturbances, rash, and yeast infections. More serious adverse effects can include severe allergic reactions, Clostridioides difficile-associated diarrhea, QT prolongation (especially with clarithromycin), and hepatotoxicity. ## Key Drug Interactions * **CYP3A4 Inhibitors/Inducers:** Clarithromycin is a potent CYP3A4 inhibitor, increasing plasma concentrations of drugs metabolized by this enzyme (e.g., certain statins, warfarin, anticonvulsants, immunosuppressants). Esomeprazole can also affect CYP2C19 and CYP3A4. * **Penicillin Allergy:** Concurrent use with other penicillins or cephalosporins should be avoided due to potential cross-reactivity. * **Warfarin:** Increased INR and bleeding risk. * **Methotrexate:** Increased methotrexate levels. * **Drugs prolonging QT interval:** Increased risk of torsades de pointes. * **Proton Pump Inhibitors:** Potential for interactions with drugs requiring gastric acid for absorption (e.g., ketoconazole, itraconazole, certain HIV medications). ## Monitoring * Monitor for signs and symptoms of allergic reactions. * Assess for and report severe diarrhea, which could indicate *C. difficile*-associated diarrhea. * Monitor for effectiveness of *H. pylori* eradication (typically via stool antigen test or urea breath test) at least 4 weeks after completion of therapy. * Monitor electrolytes (potassium, magnesium) if risk factors for QT prolongation are present. ## Clinical Pearls * This combination product is designed to simplify the regimen for *H. pylori* eradication. * Ensure patients complete the full course of therapy, even if they feel better, to maximize eradication rates and minimize resistance. * Separate administration of Sompraz HP from antacids by at least 2 hours, as antacids may reduce the absorption of the components. * Advise patients to report any signs of severe rash or difficulty breathing immediately. --- ***Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider for any questions regarding a medication or treatment. Dosing and recommendations can vary based on individual patient factors and local guidelines.*